These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 7579402)

  • 1. Autoantibodies to phosphatidylethanolamine (PE) recognize a kininogen-PE complex.
    Sugi T; McIntyre JA
    Blood; 1995 Oct; 86(8):3083-9. PubMed ID: 7579402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Certain autoantibodies to phosphatidylethanolamine (aPE) recognize factor XI and prekallikrein independently or in addition to the kininogens.
    Sugi T; McIntyre JA
    J Autoimmun; 2001 Nov; 17(3):207-14. PubMed ID: 11712858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiphosphatidylethanolamine antibodies as the only antiphospholipid antibodies detected by ELISA. II. Kininogen reactivity.
    Boffa MC; Berard M; Sugi T; McIntyre JA
    J Rheumatol; 1996 Aug; 23(8):1375-9. PubMed ID: 8856616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-phosphatidylethanolamine (aPE) antibodies: a survey.
    Mcintyre JA; Wagenknecht DR
    J Autoimmun; 2000 Sep; 15(2):185-93. PubMed ID: 10968907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphatidylethanolamine induces specific conformational changes in the kininogens recognizable by antiphosphatidylethanolamine antibodies.
    Sugi T; Mclntyre JA
    Thromb Haemost; 1996 Sep; 76(3):354-60. PubMed ID: 8883270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoantibodies to kininogen-phosphatidylethanolamine complexes augment thrombin-induced platelet aggregation.
    Sugi T; McIntyre JA
    Thromb Res; 1996 Oct; 84(2):97-109. PubMed ID: 8897699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The outcome of ELISA for antiphosphatidylethanolamine antibodies is dependent on the composition of phosphatidylethanolamine.
    Hou S; Harper PE; Bardin N; Zhao M
    J Immunol Methods; 2017 Jan; 440():27-34. PubMed ID: 27784626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kininogen domain 3 contains regions recognized by antiphosphatidylethanolamine antibodies.
    Katsunuma J; Sugi T; Inomo A; Matsubayashi H; Izumi SI; Makino T
    J Thromb Haemost; 2003 Jan; 1(1):132-8. PubMed ID: 12871550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibodies to phosphatidylethanolamine in antiphospholipid syndrome and systemic lupus erythematosus: their correlation with anticardiolipin antibodies and beta 2 glycoprotein-I plasma levels.
    Vlachoyiannopoulos PG; Beigbeder G; Dueymes M; Youinou P; Hunt JE; Krilis SA; Moutsopoulos HM
    Autoimmunity; 1993; 16(4):245-9. PubMed ID: 8025204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of the bifunctional properties of high molecular weight kininogen by studies with monoclonal antibodies directed to each of its chains.
    Schmaier AH; Schutsky D; Farber A; Silver LD; Bradford HN; Colman RW
    J Biol Chem; 1987 Jan; 262(3):1405-11. PubMed ID: 2433279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ELISA for antiphosphatidylethanolamine antibody detection: high impact of assay buffer on results.
    Sanmarco M
    J Immunol Methods; 2010 Jun; 358(1-2):9-16. PubMed ID: 20382150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular interaction of bovine kininogen and its derivatives with papain.
    Sueyoshi T; Hara A; Shimada T; Kimura M; Morita T; Kato H; Iwanaga S
    J Biochem; 1988 Aug; 104(2):200-6. PubMed ID: 3182763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [IGM hyperimmunoglobulinemia anti-phosphatidylethanolamine antibodies of the IgM isotype: clinical and biological study of 72 patients with immune disorders].
    Granel B; Serratrice J; Hubert AM; Volot F; Pache X; Swiader L; Rossi P; Disdier P; Weiller PJ
    Rev Med Interne; 2000 Jul; 21(7):595-8. PubMed ID: 10942975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiphosphatidylethanolamine antibodies and the antiphospholipid syndrome.
    Sanmarco M; Boffa MC
    Lupus; 2009 Sep; 18(10):920-3. PubMed ID: 19671793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kininogen-dependent antiphosphatidylethanolamine antibodies and autoantibodies to factor XII in patients with recurrent pregnancy losses.
    Sugi T
    J Obstet Gynaecol Res; 2013 Jul; 39(7):1223-9. PubMed ID: 23803004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiphospholipid antibodies and kininogens in pathologic pregnancies: a review.
    Sugi T; Makino T
    Am J Reprod Immunol; 2002 May; 47(5):283-8. PubMed ID: 12148543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of Anti-Phosphatidylethanolamine Antibodies in the Pathogenesis of Recurrent Pregnancy Loss.
    Yonezawa M; Kuwabara Y; Ono S; Ouchi N; Ichikawa T; Takeshita T
    Reprod Sci; 2020 Oct; 27(10):1888-1893. PubMed ID: 32548803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-phosphatidylethanolamine antibody, thromboembolic events and the antiphospholipid syndrome.
    Staub HL; Bertolaccini ML; Khamashta MA
    Autoimmun Rev; 2012 Dec; 12(2):230-4. PubMed ID: 22796282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunologic studies of human coagulation factor XI and its complex with high molecular weight kininogen.
    Bouma BN; Vlooswijk RA; Griffin JH
    Blood; 1983 Nov; 62(5):1123-31. PubMed ID: 6626744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of anti-phospholipid antibody specificities.
    Gilman-Sachs A; Lubinski J; Beer AE; Brend S; Beaman KD
    J Clin Lab Immunol; 1991 Jun; 35(2):83-8. PubMed ID: 1668762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.